Anti-Colorectal Cancer Activity of Solasonin from Solanum nigrum L. via Histone Deacetylases-Mediated p53 Acetylation Pathway
Molecules · 2023
DOI: 10.3390/molecules28186649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Xintian Lan und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China. Hauptthemen laut MEDLINE: Solanum nigrum, Solanum, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Provincial Development and Reform Commission, National Natural Science Foundation of China, Jilin Province Science and Technology Development Plan Item.
Abstract (Originalsprache)
(1)
Background
Solanum nigrum L. is a plant of the genus Solanum in the family Solanaceae and is commonly used to treat tumors. Solasonin (SS) is a steroidal alkaloid extracted from Solanum nigrum L. that has anti-colorectal cancer (CRC) activity. (2)
Methods
Column chromatography, semi-preparative HPLC and cellular activity screening were used to isolate potential anti-CRC active compounds in Solanum nigrum L., and structure identification using 1H-NMR and 13C-NMR techniques. Expression levels of HDAC in CRC were mined in the UALCAN database. The in vitro effects of SS on SW620 cell line and its mechanism were examined via Western blot, EdU staining, flow cytometry and immunofluorescence. CRC xenograft model and IHC staining were mainly used to evaluate the role of SS in vivo. (3)
Results
The results showed that SS was the most potent anti-CRC component in Solanum nigrum L., which induced apoptosis and cell cycle arrest in the SW620 cell line. HDAC was highly expressed in CRC. The treatment of SW620 cell line with SS resulted in a significant downregulation of HDAC, an increase in the level of P53 acetylation and a subsequent increase in the level of P21. The in vivo validation results showed that SS could effectively inhibit CRC growth, which was associated with the downregulation of HDAC. (4)
Conclusions
SS treatment for CRC mainly works through the induction of apoptosis and cycle arrest, and its mechanism of action is mainly related to HDAC-induced P53 acetylation, and the HDAC/P53 signaling pathway may be a potential pathway for the treatment of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
- Key Laboratory of Effective Components of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China.
Förderung
- Jilin Provincial Development and Reform Commission
- National Natural Science Foundation of China
- Jilin Province Science and Technology Development Plan Item
Zitieren
APA
Lan, X., Lu, M., Fang, X., Cao, Y., Sun, M., Shan, M., Gao, W., Wang, Y., Yu, W., & Luo, H. (2023). Anti-Colorectal Cancer Activity of Solasonin from Solanum nigrum L. via Histone Deacetylases-Mediated p53 Acetylation Pathway. Molecules. https://doi.org/10.3390/molecules28186649
Vancouver
Lan X, Lu M, Fang X, Cao Y, Sun M, Shan M, et al. Anti-Colorectal Cancer Activity of Solasonin from Solanum nigrum L. via Histone Deacetylases-Mediated p53 Acetylation Pathway. Molecules. 2023. doi:10.3390/molecules28186649
BibTeX
@article{Lan2023,
author = {Lan, Xintian and Lu, Meng and Fang, Xiaoxue and Cao, Yiming and Sun, Mingyang and Shan, Mengyao and Gao, Wenyi and Wang, Yuchen and Yu, Wenbo and Luo, Haoming},
title = {Anti-Colorectal Cancer Activity of Solasonin from Solanum nigrum L. via Histone Deacetylases-Mediated p53 Acetylation Pathway},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28186649}
}
EUVIMED